Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease is a research paper published in Neurobiology of Disease (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: AG018440
National Institute on Aging
Grant: AG072053
National Institute on Aging
Grant: AG073979
National Institute on Aging
Grant: P30-AG066530
National Institute of Neurological Disorders and Stroke
Grant: P30NS047101
NIA NIH HHS
Grant: RF1 AG072053
NIA NIH HHS
Grant: R01 AG018440
NIA NIH HHS
Grant: R37 AG018440
NIA NIH HHS
Grant: RF1 AG073979
NIA NIH HHS
Grant: P30 AG066530
NIA NIH HHS
Grant: R01 AG073979
National Institutes of Health
Grant: 1R01AG073979-01
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome
National Institutes of Health
Grant: 5R37AG018440-13
a-synuclein clearance strategies for the treatment of Lewy body disease
National Institutes of Health
Grant: 5P30NS047101-07
project 1
National Institutes of Health
FWCI
2.20
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals